戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 zation is consistent with that of large cell immunoblastic lymphoma.
2 iferative disorders to aggressive monoclonal immunoblastic lymphomas.
3 tologic subgroup, the large-cell diffuse and immunoblastic lymphomas.
4 e lung transplant recipient who developed an immunoblastic lymphoma 4 months after lung transplantati
5 n thus be used safely to prevent EBV-related immunoblastic lymphoma after allogeneic marrow transplan
6 a distinctive morphology bridging large-cell immunoblastic lymphoma and anaplastic large-cell lymphom
7 sistent with previous findings in large cell immunoblastic lymphomas and indicates that this enzyme m
8 ansformed lymphoblastoid cell lines and AIDS immunoblastic lymphoma, and plasma cells, as defined by
9 h Working Formulation intermediate grade and immunoblastic lymphomas (exclusive of mantle cell) and s
10 mphoma and most high-grade tumors, including immunoblastic lymphomas, expressed minimal amounts of hs
11 ve prophylaxis and treatment of EBV-positive immunoblastic lymphoma in immunocompromised patients.
12 n-Barr virus (EBV) causes potentially lethal immunoblastic lymphoma in up to 25% of children receivin
13 s, showed them to be most closely related to immunoblastic lymphomas, less so to plasmacytomas of Fas
14 lly significant class of AIDS NHL designated immunoblastic lymphoma plasmacytoid (AIDS IBLP) lacks an
15  not receive prophylaxis and developed overt immunoblastic lymphoma responded fully to T-cell infusio
16                    We report the case of a B-immunoblastic lymphoma that developed in a pretransplant
17 bset of patients with intermediate-grade and immunoblastic lymphoma, the 3-year DFS was 89% (95% CI,
18 newly diagnosed patients with large-cell and immunoblastic lymphoma who participated in prospective c
19  were 42 patients with intermediate-grade or immunoblastic lymphoma who were considered to be high (6
20 c appearance of high-grade anaplastic/B-cell immunoblastic lymphomas, with loss of B-cell differentia

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。